Dena Evans, EdD(c), MPH, BSN, RN, CNE Assistant Professor

21 Slides1.87 MB

Dena Evans, EdD(c), MPH, BSN, RN, CNE Assistant Professor Department of Nursing The University of North Carolina at Pembroke

See Routine Orders pg. 857

Prevent uterine atony Relive pain Enhance or suppress lactation Promote bowel function Enhance immunity

NSAIDS May prolong bleeding time Take with food or water GI upset Narcotics

Systemic analgesics Decreased alertness Opioids Bowel function Respirations

Redness Ecchymosis Edema Discharge Approximation

Witch hazel Nupercainal onitment Nonpharmacological Sitz baths

Medications not used/less popular due to side effects Chlorotrianisene (Tace) Deladumone OB Bromocriptine mesylate (Parlodel) You may be asked about these by a family member Now-support bras, breast bindings, axillary ice packs

Flatus Antiflatulants Ambulation Increase water intake High-fiber foods

Colace Peri-Colace Dulcolax MOM Mineral Oil Nursing Process Laxatives-pg. 864

Rho D Immune Globulin Explain erythroblastosis fetalis Direct vs. Indirect Coomb’s test

Given prenatally in approx. 1-2% of Rh- women. Assessed at initial prenatal visit and again at 28-29 weeks. Can be given IM within 72 hours after delivery Routinely given after maternal/fetal blood mixing. Human D immunoglobulin Religious Beliefs**

AKA German Measles High rate of abortion, neurological defects Congenital rubella syndrome First Trimester-risk After First Trimester-less risk Vaccine is contraindicated during pregnancy

Burning at injection site acidic pH of vaccine. Urticaria-allergic reaction Malaise Fever Headache Arthralgia Moderate fever

Hypotension Chills Dizziness Headache Pruritis Injection site reaction Have epinephrine available to treat anaphylaxis

Erythromycin Ophthalmic Ointment Vitamin K Anti-infective agents (cord stump) Literature supports drug cord care

EES-chemical conjunctivitis Vitamin K-prevents bleeding Pain and edema at injection site Allergic reaction Hyperbilirubinemia and jaundice Bilirubin and Vitamin K protein binding sites

HBV Require maternal consent (signed) Number based on mothers HBsAg status IM-vastus lateralis (preferred site) or rectus femoris Negative-only one injection Positive-two HBV vaccine AND HBIG (hepatitis B immune globulin)

Page 872

Back to top button